Drugs / Porcine Fibrin Sealant (PFS)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03847857 | Feb 2019 → Jul 2023 overdue | — | Sun Yat-sen University | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Porcine Fibrin Sealant (PFS) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03847857 ↗ |
| Known as | Bioseal | “Bioseal® (Guangzhou Bioseal Biotech Co., Ltd., China) is a porcine-derived fibrin sealant that has been widely used in various surgical procedures to assist in hemostasis for...” NCT03847857 ↗ |
| Modality | Protein / enzyme biologic | “This type of fibrin sealant is made from biologically porcine-derived thrombin and fibrinogen” NCT03847857 ↗ |